Adar1 Capital Management, LLC Arvinas, Inc. Transaction History

Adar1 Capital Management, LLC

  • $500 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$23.66 - $32.73 $283,920 - $392,759
-12,000 Reduced 37.04%
20,400 $502 Million
Q2 2024

Aug 13, 2024
BUY
$24.46 - $40.4 $151,652 - $250,480
6,200 Added 23.66%
32,400 $862 Million
Q1 2024

May 15, 2024
BUY
$36.38 - $52.31 $953,156 - $1.37 Million
26,200 New
26,200 $1.08 Billion

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
70.9M
Call Options Held
1.52M
Put Options Held
346K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $945M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email